Tectorigenin Alleviates Inflammation, Apoptosis, and Ossification in Rat Tendon-Derived Stem Cells via Modulating NF-Kappa B and MAPK Pathways

Safwat Adel Abdo Moqbel,Kai Xu,Zhonggai Chen,Langhai Xu,Yuezhe He,Zhipeng Wu,Chiyuan Ma,Jisheng Ran,Lidong Wu,Yan Xiong
DOI: https://doi.org/10.3389/fcell.2020.568894
IF: 5.5
2020-10-22
Frontiers in Cell and Developmental Biology
Abstract:Tendinopathy is a common musculoskeletal disorder that mainly affects athletes and people of older age. Tumor necrosis factor-α (TNF-α) plays an important role in initiating tendinopathy. Tectorigenin, an extract component of <i>Belam-canda Chinesis</i>, possesses anti-inflammatory and anti-apoptosis activity. The present study was established to investigate the role of tectorigenin against the pathogenetic effects of TNF-α on tendon-derived stem cells (TDSCs) <i>in vivo</i> and <i>in vitro</i>. The findings indicated that TNF-α is able to induce TDSC inflammation, apoptosis, and ossification, as well as activate nuclear factor-kappa B and mitogen-activated protein kinase (MAPK). Furthermore, the results confirmed that tectorigenin is able to inhibit the TNF-α-induced inflammation, apoptosis, and ossification. Tectorigenin treatment decreases activation of NF-kappa B and MAPK signaling in TDSCs. Tectorigenin ameliorates tendinopathy in the <i>in vivo</i> rat model. Thus, these data reveal that tectorigenin can serve as a potential treatment for tendinopathy.
cell biology,developmental biology
What problem does this paper attempt to address?